Has Shilpa Raval, DO received payments from drug or device companies?

Yes. Drug and device makers reported $1,992 in general payments to Shilpa Raval, DO across 83 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Shilpa Raval, DO did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Shilpa Raval, DO come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Shilpa Raval, DO

Internal Medicine · Pompano Beach, FLNPI 1295318830

Payments from drug & device makers

$1,992in general payments, 2019–2025

Across 83 payments — averaging $24.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$608
AbbVie$253
Novartis$223
Dexcom, Inc.$198
Medtronic$139
Novo Nordisk$135
plus $436 from 6 others

What the payments were for

Food & beverage$1,92497%
Education$693%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca	26	$608
AbbVie	8	$253
Novartis	17	$223
Dexcom, Inc.	4	$198
Medtronic	3	$139
Novo Nordisk	6	$135
Vivus LLC	6	$121
Lilly USA, LLC	6	$100
Astellas Pharma US Inc	2	$94
Boehringer Ingelheim	2	$55
Phathom Pharmaceuticals, Inc.	2	$45
Xeris Pharmaceuticals, Inc.	1	$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,992 in reported general payments places this provider in the 75th percentile of 8,530 internal medicine providers in Florida.

See all internal medicine providers in Florida →

Medicare billing

Part B allowed, 2024

$4,619

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Pompano Beach

Yaneicy Gonzalez RojasCoral Gables$93.5M
Juan Carlos RondonHollywood$66.8M
Jaynier MoyaPembroke Pines$45.4M
Mark KutnerMiami$35.7M
Gilberto JimenezHialeah$35.6M
Mira BaronWest Palm Beach$29.6M
William SanchezHialeah$28.9M
Nelia Sanchez-CrespoHollywood$28.8M
Kwabena AyesuOrlando$27.6M
Michael DeverWindermere$24M

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →